Furthermore, a study by Lazear et al. suggested that the IFN family may represent a promising direction for psoriasis treatment [42], while our study revealed the IFN receptor proteins IFNLR1 and IFNGR2, highlighting their therapeutic potential for PsO. Here, IFNGR2 is linked to psoriasis.